insights_auto
Why is NTRA up 3.73%?
Dive Deeperchevron_right
NTRA:NASDAQ
Natera Inc
$425.64
arrow_upward
+3.73%(+15.29) 1D
$425.64
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 5, 3:59:55 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NTRA...
Open
$410.32
High
$427.18
Low
$405.24
Mkt. cap
61.35B
Avg. vol.
1.49M
Volume
1.47M
52-wk high
$427.47
52-wk low
$167.22
EPS
-$1.37
Beta
1.50
Shares outstanding
144.14M
No. of employees
6K
Open
$410.32
High
$427.18
Low
$405.24
Mkt. cap
61.35B
Avg. vol.
1.49M
Volume
1.47M
52-wk high
$427.47
52-wk low
$167.22
EPS
-$1.37
Beta
1.50
Shares outstanding
144.14M
No. of employees
6K
News stories
From web sources and news partners
Investing.com Canada
·
6 hours ago
Natera, AFT launch phase III breast cancer trial By Investing.com
Stock Titan
·
8 hours ago
A trial will test whether a blood test can spare some breast cancer patients an added drug
AD HOC NEWS
·
10 hours ago
Natera stock gets Japan approval for Signatera expansion
Investing.com
·
2 days ago
Natera CEO Steven Chapman sells $526k in common stock
Profile
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
About Natera Inc
CEOSteven Chapman
Employees6.14K
FoundedJan 1, 2004
HeadquartersAustin, Texas, United States
SectorBiotechnology
Websitenatera.com